As cinacalcet inhibited the production of inflammatory cytokines and TNFα-stimulated NF-κB activity plays a crucial role in the pathogenesis of IBD, we further tested whether the suppression of cytokine production mediated by cinacalcet occurred via NF-κB activity inhibition. The gene discussed is NFKB1; the disease is inflammatory bowel disease.